SNO 2021: Trametinib Shows Promise for Recurrent/Refractory Pediatric LGG
Children with activation of the MAPK/ERK pathway benefited.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.